FYI
"Respected Florida based US research house Redchip, has re-rated ASX listed cancer drug hopeful Pharmaust at 35c a share, almost triple its current share price. The total Net Present Value calculated by Redchip for Pharmaust out to 2030 is $56.5m, considerably higher than Pharmaust's current market cap that hovers between $10m and around $12m. "
Full article:
https://www.businessnews.com.au/article/US-research-house-tips-Pharmaust-shares-to-triple?utm
FYI "Respected Florida based US research house Redchip, has...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $99.71M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $64.86K | 317.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 42245 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 89755 | 2 |
View Market Depth
| Last trade - 13.30pm 27/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |